1.Risk factors and mechanisms of post-stroke depression
Peijia SHAN ; Yingqi ZHOU ; Xiaoying BI ; Yiqing QIU ; Shi WANG
International Journal of Cerebrovascular Diseases 2012;(12):939-942
Depression is a common complication after stroke.It is often associated with disability,cognitive impairment,and increased mortality.This article reviews the epidemiology,risk factors,predictive factors,and pathophysiology mechanisms of post-stroke depression.
2.Micro?surgical Treatment of Medulla Oblongata Cavernomas
Pengfei WU ; Minghao WANG ; Xiao CUI ; Wei WANG ; Dan ZHAO ; Jiyuan LIU ; Yue MA ; Yingqi WANG ; Bo QIU ; Jun TAO ; Yunjie WANG
Journal of China Medical University 2017;46(6):505-509
Objective To investigate the efficacy of micro?surgery for the treatment of medulla oblongata cavernomas. Methods A retrospective analysis was conducted on the clinical data of 21 patients with cavernous hemangioma who received micro?surgical treatment. Of the 21 patients, 13 were men and 8 women,aged 22 to 63 years. The preoperative Karnofsky performance status(KPS)score was 76.5 ± 10.2. The main clinical manifestations included sensory disorder and difficulty swallowing etc. According to the location of the lesions ,the posterior transchoroidal fissure approach was employed for 16 patients;far?lateral approach,5 patients. Electrophysiological monitoring and nervous system navigation were supple?mentarily adopted in both types of surgery. Further ,KPS scoring was conducted to evaluate the patients 'quality of life. Results The medulla cav?ernous hemangioma was excised in all cases. For 17 patients with primary neurological disorders ,their symptoms were alleviated or resolved;4 pa?tients had severe symptoms and 8 presented with new clinical symptoms. A follow?up visit was conducted 8 to 97 months post?surgery(average 47.6 months). All patients were found capable of caring for themselves in daily life and performing simple or normal learning and working activities without recurrence or bleeding. The mean postoperative KPS score was 83.7 ± 15.5. Conclusion Patients with medulla cavernous hemangioma bleeding or severe symptoms should actively seek surgical treatment. Repeated bleeding is the absolute indication for surgery. Surgical skills ,elec?trophysiological monitoring,and nervous system navigation can reduce nervous system damage and protect the brainstem. The patient's quality of life is expected to significantly improve after surgery.
3.Comparison of the efficacy of 3 kinds of drugs such as Danning tablet on preventing the recurrence of choledo-cholithiasis after endoscopic retrograde cholangiopancreatography
Yingqi SHI ; Meiqin SHEN ; Jianwei QIU
China Pharmacy 2023;34(15):1874-1878
OBJECTIVE To compare the efficacy of Danning tablet, taurosodeoxycholic acid and ursodeoxycholic acid in preventing the recurrence of choledocholithiasis after endoscopic retrograde cholangiopancreatography (ERCP). METHODS The clinical data of 153 patients who underwent ERCP choledocholithotomy from January 2017 to January 2020 in Nantong First People’s Hospital were retrospectively analyzed. According to the different drug treatment received after surgery, patients were divided into three groups, namely, Danning tablet group (group A, 49 cases), tauroursodeoxycholic acid group (group B, 44 cases) and ursodeoxycholic acid group (group C, 60 cases). The above groups of drugs are all single-use, starting from 2 weeks after surgery for a course of 180 days. The effects of bile component indicators [total bilirubin (Tbil), direct bilirubin (Dbil), alkaline phosphatase (ALP), glutamyltransferase (GGT)], lipid metabolism indicators [total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL)], the occurrence of clinical symptoms (abdominal pain, bloating, nausea, and poor appetite) at 6 months after ERCP, and the recurrence of choledocholithiasis at 6, 12, 18 and 24 months after surgery were compared among 3 groups. RESULTS Compared with before surgery, the serum levels of Tbil, Dbil, ALP, GGT, TC, TG and LDL were significantly reduced (P<0.05), while serum HDL levels were significantly increased (P<0.05) in the three groups at 6 months after surgery. The proportion of patients who experienced abdominal pain, bloating, nausea, and poor appetite at 6 months after surgery was significantly reduced (P<0.05). The Tbil levels of groups A and B were significantly lower than those of group C (P<0.05), while the Dbil and ALP levels of group A were significantly lower than those of groups B and C (P<0.05); however, there was no statistically significant difference in GGT levels among the 3 groups (P>0.05). Compared with groups A and C, the levels of four lipid metabolism indicators in group B were significantly improved (P<0.05); the proportion of patients with abdominal pain, bloating, and poor appetite in group A was significantly lower than groups B and C (P<0.05), but there was no statistically significant difference in the proportion of patients with nausea among the 3 groups (P>0.05). At 6,12 and 18 months after surgery, there was no statistically significant difference in the rate of choledocholithiasis recurrence among the 3 groups (P>0.05); at 24 months after surgery, the rate of choledocholithiasis recurrence in group A (2.04%) was significantly lower than group B (15.91%) and group C (15.00%) (P<0.05). CONCLUSIONS Compared with tauroursodeoxycholic acid and ursodeoxycholic acid, the application of Danning tablet after ERCP is more beneficial to reduce the secretion of bile acid, prevent the recurrence of gallstones, and improve clinical symptoms, but tauroursodeoxycholic acid can significantly accelerate the lipid metabolism of patients compared with the other two drugs.
4.Efficacy of human umbilical cord mesenchymal stem cells via different transplantation approaches in treatment of rats with liver cirrhosis
Yingqi QIU ; Hongwei WANG ; Hongyan ZHU ; Hongliang YU ; Fan XIE ; Cuibao JIANG
Journal of Clinical Hepatology 2023;39(12):2851-2857
ObjectiveTo investigate the therapeutic effect of the frozen and fresh preparations of human umbilical cord mesenchymal stem cells (hUC-MSC) on a rat model of liver cirrhosis after transplantation via the portal vein or the caudal vein. MethodsA total of 70 specific pathogen-free healthy male Sprague-Dawley rats were randomly divided into normal group (13 rats fed with ordinary tap water and rat food) and liver cirrhosis model group (57 rats given subcutaneous multi-point injection of mixed carbon tetrachloride/olive oil solution). At week 8, the growth of rats was observed for both groups, and 3 rats were selected from each group for histopathological examination to confirm the formation of liver cirrhosis. A total of 50 rats were selected from the liver cirrhosis model and were divided into model group, portal vein group+fresh cell preparation group, portal vein+frozen cell preparation group, caudal vein+fresh cell preparation group, and caudal vein+frozen cell preparation group using a random number table, with 10 rats in each group. Fresh or frozen hUC-MSC were transplanted via the portal vein or the caudal vein, and after 4 weeks of administration, the different groups were compared in terms of the changes in liver function parameters and liver fibrosis degree. Continuous data were expressed as mean±standard deviation, and the independent-samples t test was used for comparison between two groups; a one-way analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for further comparison between two groups. ResultsAt week 8 of modeling, the model group showed the formation of pseudolobules of different sizes in the liver and met the diagnostic criteria for liver cirrhosis, with significant increases in the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBil), and alkaline phosphatase (ALP) compared with the normal group (all P<0.001), suggesting that the rat model of liver cirrhosis was established successfully. There were significant differences in the levels of ALT, AST, TBil, and ALP between the five groups (F=232.00, 177.10, 112.30, 121.70, all P<0.001). Further comparison between two groups showed that the model group had significantly higher levels of ALT, AST, TBil, and ALP than the normal group (all P<0.01), and the portal vein group+fresh cell preparation group, the portal vein+frozen cell preparation group, the caudal vein+fresh cell preparation group, and the caudal vein+frozen cell preparation group had significantly lower levels of ALT, AST, TBil, and ALP than the model group (all P<0.01). ConclusionThere are significant improvements in liver function and liver fibrosis degree in a rat model of liver cirrhosis at week 4 after the transplantation of hUC-MSC, and frozen or fresh cell preparation and different transplantation approaches have no significant influence on treatment outcome.